Business NewsPR NewsWire • DiamiR Announces Oral Presentation at 21st International Conference on Alzheimer's Drug Discovery

DiamiR Announces Oral Presentation at 21st International Conference on Alzheimer's Drug Discovery

DiamiR Announces Oral Presentation at 21st International Conference on Alzheimer's Drug Discovery

MONMOUTH JUNCTION, N.J., Oct. 5, 2020 /PRNewswire/ -- DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Dr. Kira Sheinerman, Chief Executive Officer, will be presenting and participating in a panel...

View More : https://www.prnewswire.com:443/news-releases/diamir-announces-oral-presentation-at-21st-international-conference-on-alzh...
Releted News by prnewswire
WD-40 Company Declares Regular Quarterly Dividend
Wallis Bank Participates in ABA's #BanksNeverAskThat Anti-Phishing Campaign
DiamiR Announces Oral Presentation at 21st International Conference on Alzheimer's Drug Discovery
Tobii divests Smartbox